Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50

NCT07313462 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT07313462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07313462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Recruiting
Start date
February 7, 2025
Completion date
February 28, 2026
Enrollment
830 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms)